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ABSTRACT
Objectives: In recent years, the rapid development of minimally invasive surgical methods, including robotic surgery, has 
resulted in a marked decline of the traditional methods in gynaecological surgery. The aim of the study was to share our 
experience with robotic surgery at a state hospital. 
Material and methods: A total of 40 patients, who underwent robotic gynaecological surgery (GS) between 2015 and 2017, 
were included. Age, BMI, previous abdominal operations (PAO), operation indications (OI), operative time (OT), pathological 
evaluation, uterine weight (UW), blood loss during surgery (BL), complications, and duration of the hospitalization (DoH) 
were analyzed. The Da Vinci XI was used during surgery. 
Results: A total of 40 patients were analyzed. Mean values were as follows: age — 48 years, BMI — 28, and PAO — 12%. 
The most common OI included uterine fibroids (52%) and abnormal uterine bleeding (45%). Mean OT, docking time and 
console time values were 166 min, 15 min, and 123 min, respectively. Mean BL was 93 mL. Mean UW was 256 gr, and DoH 
was 4 days. Perioperative and postoperative complications were observed in 10% and 20% of the cases, respectively. 
Conclusions: Robotic-assisted surgery is invaluable in gynaecology, especially in the case of endometriosis, extensive adhe-
sion, and in some oncological patients, as it allows for better visualization and higher maneuverability. In order for a surgeon 
to prepare for such cases, the use of the robot in benign cases is necessary to complete the learning curve and gain speed.
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INTRODUCTION
Recent years have witnessed a rapid improvement of 
minimally invasive surgical methods, which in turn has slow-
ly but steadily started to dethrone conventional methods 
in gynaecology [1, 2]. Undoubtedly, the introduction of the 
da Vinci robot into the field of surgery greatly contributed 
to that process. The first robotic hysterectomy was carried 
out in 2005 in the USA and ever since, da Vinci has been 
extensively used, especially in urologic cases [3–5].
Technically, the Da Vinci robotic system consists of 
3 parts: surgeon console, 3D-HD monitoring system, and 
robotic arms manipulated by the surgeon. The system, due 
to its various advantages, is far superior to the conventional 
laparoscopy. A robotic system reduces physiological trem-
ors in the hands of the surgeon to the minimum, provides 
540 degrees of maneuverability by mimicking the exact 
movements of the surgeon’s wrist, and decreases the back 
and neck injuries of the surgeon as a result of improved 
ergonomics. The disadvantages of laparoscopic surgeries in-
clude limited maneuverability as well as deteriorated display 
quality, and the necessity to control the equipment by hand, 
while the robotic camera provides perfect display quality by 
enlarging the image (10–20 x magnification). Robotic surgery 
ensures ergonomic comfort and the camera is controlled by 
the surgeon [6]. Robot-assisted surgery has clinical advantag-
es also for the patient, i.e. smaller incisions, less perioperative 
blood loss, shorter hospitalization, quicker return to the daily 
activities, less postoperative pain, and fewer complications 
[5, 7]. Due to the fact that the manipulation rate in the robotic 
system is similar to the open surgery, the learning curve has 
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been observed to be shorter as compared to laparoscopy [8]. 
However, robotic surgery is not cost-effective as compared 
to the classic procedures [9, 10].
Hysterectomy is a common surgical solution as far as uter-
ine complaints are concerned. In the USA, it is the second most 
frequent operation after C-section [9], and the most common 
procedure among the robotic gynaecological operations. 
The aim of the study was to share our initial experiences 
with robotic hysterectomy. 
MATERIAL AND METHODS
A total of 40 patients who underwent a robotic gynae-
cological operation at the /…/ Maternity Hospital between 
2015–2017 was analyzed. Local Ethics Committee approved 
of the study. 
Apart from 1 subject, all patients had benign pathology 
and total hysterectomy was performed in all cases. The 
indications were similar to the usual indications for hyster-
ectomy (Tab. 2).
Age, BMI, history of abdominal operations/C-sections, 
indications for surgery, operative time (first incision, port 
placement, docking, console time, undocking, and stitch-
ing time were included), pathological evaluation, uterine 
weight, blood loss during operation, complications and 
duration of the hospitalization were recorded. 
Da Vinci XI was used in all surgeries. An identical number 
of ports was placed in all patients: 1 camera port, 3 ports 
for the arms of the robot, and 1 assistant port. The uterine 
manipulator was docked between the legs. The patient was 
operated on from the right side. A 0-degree camera and 
a 30-degree camera were used. Specimens were evacu-
ated through the vaginal cuff gap, which was sutured using 
absorbable monofilament sutures (size 0) made of polyg-
lycolic acid. The same surgical team performed all opera-
tions. Lymphadenectomy was found to be unnecessary for 
the one patient who was operated for endometrial carci-
noma since < 50% myometrial involvement was detected. 
Statistical analysis
Mean, standard deviation and percentages were evalu-
ated. Additionally, correlations between BMI-operative time 
and uterine weight- operative time were investigated. 
Table 1. Parameters
Mean SD n %
Age [year] 47.78 4.27 40
BMI [kg/m2] 28.18 4.27
Previous abdominal operations 6 15
Skin-to-skin operative time [min] 166.00 33.40
‘Docking’ time [min] 15.06 5.54
‘Console’ time [min] 122.25 29.46
Complications
Perioperative 4 10
Postoperative 8 20
Uterine weight [g] 255.98 86.41
Hospitalization time [days] 4.25 1.33
Perioperative bleeding volume [mL] 92.75 122.25
Table 2. Indications and operations
Indication n (%) Explanation (Accompanying pathology) Operations
Myoma uteri 9 (22.5)
Robot-assisted hysterectomy
bilateral/unilateral oophorectomy
sub-total hysterectomy (1 case)
culdoplasty
Sacrouterine plication (1 case)
intestine meso-repair (1 case)
Adhesiolysis
Myoma uteri+ other 12 (30)
Bilateral ovarian mass, adenomyosis, HSIL, level 
1 uterineprolapse, subserosalmyoma, pelvic pain, 
endometrioma
Abnormal uterinebleeding 5 (12.5)
Abnormal uterine 
bleeding + endometrial 
pathology
13 (32.5) Chronic endometritis, endometrial polyp, endometrial hyperplasia (with or without atypia), tubal metaplasia
Endometrialcarcinoma 1 (2.5) Well-differentiated endometrioid adenocarcinoma
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RESULTS
In this study, data of 40 patients were retrospectively an-
alyzed. Mean values for age and BMI were 47.78 ± 4.27 years 
(ages: 43–61) and BMI 28.18 ± 3.76 (BMI: 23–41), respectively. 
The rate of previous abdominal operations was 12.5%. The 
most common indications for surgery were uterine fibroids 
(52.5%) and abnormal uterine bleeding (45%) (Tab. 1 and 2).
Mean skin-to-skin operative time was 166 ± 33.4 min 
(110–245 min). Mean docking and console times were 
15.01 ± 5.55 min (6–28 min) and 122.75 ± 29.24 min (80–
190 min), respectively. In our study, we did not observe 
a statistically significant correlation between BMI and op-
erative time (r = 0.25; p > 0.05; Fig. 1). Also, no statistically 
significant correlations were found between uterine weight 
and operative time (r = 0.33; p > 0.05; Fig. 2).
Mean blood loss during surgery was 92.75 ± 122.25 mL 
(0–750 mL). Mean uterine weight was 255.93 ± 96.63 gr 
(150–490 gr), and the mean duration of hospitalization was 
4.25 ± 1.33 days (2–7 days) (Fig. 2).
Peri-operative complications were observed in 4 pa-
tients (10%). In 1 patient, the robotic arms did not work 
due to the sheer size of the myoma. Hence, it was not pos-
sible to ligate the uterine artery. As the bleeding continued, 
conversion to laparotomy was necessary (2.5%). In another 
patient, the operation was completed but, while the needle 
was being taken out, it dropped into the abdomen. It was 
found with the help of a scope but the operative time was 
extended. In yet another patient, perioperative hematuria 
was formed. It was detected by cystoscopy and repaired. 
Calcified bladder tumour and hematuria are formed as a re-
sult of irritation caused by the uterine manipulator. Finally, 
in one patient, an intestine meso-defect was formed due to 
trocar injury and was repaired. 
Also, complications during the post-operative period were 
observed in 8 (20%) patients, including 1 case of bleeding from 
the paravaginal artery due to insufficient cauterization during 
the postoperative period (the patient underwent laparotomy 
during the first postoperative hour), 1 case of partial intestinal 
obstruction in the assistant port gap on postoperative day 
3 in a morbidly obese patient (the fascial defect repair was 
performed), and 6 cases of non-specific cardiopulmonary 
obstructions (tachycardia, suspicion of pulmonary embolism, 
chest pain, difficulty in breathing and an asthma attack).  
DISCUSSION
Recent advances in robotic surgery have resulted in 
a wide range of possible applications in gynaecological cases 
[1, 2]. A considerable learning period of the conventional 
laparoscopic methods and their limitations, as well as 
technological developments, are the reasons why more 
surgeons become inclined to try robotic surgery. Although 
the Da Vinci surgical system was first used in the USA already 
Figure 1. Correlation between BMI and operative time
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in 1999 and was approved by the FDA in the same year, its 
application in the field of gynaecological surgery did not 
happen until 2005 [4]. The first documented usage of Da 
Vinci during a gynaecological operation in our country was 
in 2010 [11], and in our hospital in 2015. 
Robotic surgery which is used for various gynaecological 
indications is most frequently applied in benign processes 
such as uterine fibroids, uterine bleedings resistant 
to treatment, endometrial pathologies, ovarian cysts, 
endometrioma, tubal pathologies, re-anastomosis, and 
some gynecologic oncology cases [12, 13].
Various studies presenting experiences with robotic 
surgery focus on the analysis of operative time, BMI, 
perioperative bleeding volume, complications and duration 
of hospitalization. 
Operative time varies greatly between different 
series of robotic surgery applications. In a hysterectomy 
and myomectomy series of 16 patients conducted by 
Reynolds RK et al., in 2006, using an FDA-approved Da 
Vinci, mean operative time was 242 min [4]. Mean operative 
time of 75 hysterectomy cases by Goetghluck Jet al., was 
128 min [14], and in a polycentral meta-analysis presented 
by Albright et al., in 162 robotic hysterectomy cases skin-
to-skin operative time was 108-177 min [15].
As for our study sample, composed of benign 
pathologies, the use of the same surgical team (primarily 
for hysterectomy) and the same number of ports in each 
patient allowed us to create a more homogeneous patient 
population. In light of the fact that preparation time before 
surgery (time before entry, anesthetization, and positioning) 
may vary considerably, we included the docking and 
undocking times and analyzed skin-to-skin operative time 
(which was 166 min.) in order to keep the margin of error 
to the minimum. In one study, mean docking time was 
4.2 min, with the trainer involved [16]. An observer was 
present during three of our operations, in others, the trainer 
was not involved. 
In our study, the average docking time was 15.06 min. It 
is necessary to perform more operations in order to address 
the following: wide range of indications for robotic surgery, 
not having the same surgical team, lack of experience in 
the first cases, not using standard parameters, especially 
while calculating the operative time, and selection 
of the heterogeneous study population, in hopes of 
standardization. 
The effects of BMI on the operative time were 
investigated by other authors, e.g. Gutierrez et al., reported 
a significant correlation between BMI and the operative time 
in robotic hysterectomies due to benign uterine diseases 
[16]. However, in our study, we did not observe a significant 
correlation between BMI and the operative time. In the 
same study as mentioned above, no significant correlation 
between uterine weight and operative time was found, 
which is consistent with our results.
One of the most important advantages of robotic surgery 
is low operative blood loss [12]. According to the literature, 
blood loss is considerably lower in robot-assisted surgery 
as compared to the conventional methods [14, 15]. In our 
study, besides the cases without bleeding, mean blood 
loss volume was 92 mL. The high bleeding rate in our series 
Figure 2. Correlation between uterine weight and operative time
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was due to the negative processes encountered in two 
cases. The one with the giant myoma uteri was an example 
of an erroneous selection and consequently, the robotic 
arms did not work properly so that the uterine artery was 
not ligatured. In the other one, approximately 200 mL of 
blood were lost due to insufficient cauterization of one of 
the paravaginal arteries. Laparotomy was performed in both 
cases. As we have mentioned, sometimes it is necessary to 
convert to laparotomy. The rate of these cases in the series 
by Goetghluck et al., with 75 robotic hysterectomy cases, 
was 2.7% [14]. In a meta-analysis with 326 patients that rate 
was 0.9% (3/326) [15], and in another polycentral analysis of 
2300 cases, the rate was 0.1% [12]. In yet another study, the 
rate of conversion to laparotomy was higher in laparoscopic 
surgery as compared to robotic surgery [17].
In 2095 patients who underwent robotic hysterectomy, 
the most common postoperative complications were related 
to urinary (1.8%) and gastro-intestinal (0.9%) systems, 
while less frequent postoperative complications were 
cardiovascular and pulmonary (0.1% and 0.4%, respectively) 
[12]. In this study, 15% of nonspecific cardiopulmonary 
symptoms were observed. 
The cost of robotic surgery is not to be ignored. Higher 
costs of robotic surgery, as compared to the conventional 
laparoscopy, are associated with the fact that advanced 
technology is used [5, 10]. The approximate cost in our 
study was USD 1500–2000 per case. Although this number 
could be considered as high, it is expected that after 
adaptation time the costs of the operations would be 
more convenient, especially in oncological and advanced 
endometriosis cases. Hospitalization time is another factor 
which affects the cost. In our study, the mean hospitalization 
time was 4.25 days. In contrast, in the literature, the 
mean hospitalization time was 1.1–3.5 days [14, 15]. 
Aarts et al., did not detect significant superiority of 
RH in gynaecology [18]. In a study by Simpson et al., it 
is underlined that there were differences regarding the 
opinions on the benefits of robotic surgery between the 
users and the literature [19]. In an article by Andres et al., 
robotic surgery in benign uterine diseases was not found 
to be superior to other classic methods [20].
CONCLUSIONS
In conclusion, robot assistance in gynaecological 
surgery is vital, especially in endometriosis, cases with 
advanced adhesion, and some oncological patients as it 
allows for a better display and higher maneuverability. The 
use of a robot in benign cases is important in order for the 
surgeon to complete the learning curve and gain speed, 
which will later be applied in the abovementioned more 
serious cases.
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